The metalloendopeptidase nardilysin (NRDc) is potently inhibited by heparin-binding epidermal growth factor-like growth factor (HB-EGF).
暂无分享,去创建一个
A. Prat | N. Seidah | M. Klagsbrun | E. Nishi | P. Cohen | V. Hospital
[1] M. Klagsbrun,et al. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate , 1993, The Journal of cell biology.
[2] M. Klagsbrun,et al. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. , 1995, Molecular biology of the cell.
[3] S. Kuhara,et al. A yeast gene necessary for bud-site selection encodes a protein similar to insulin-degrading enzymes , 1994, Nature.
[4] C. Fahy,et al. Enzymes processing somatostatin precursors: an Arg-Lys esteropeptidase from the rat brain cortex converting somatostatin-28 into somatostatin-14. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[5] G. Besner,et al. Interaction of heparin-binding EGF-like growth factor (HB-EGF) with the epidermal growth factor receptor: modulation by heparin, heparinase, or synthetic heparin-binding HB-EGF fragments. , 1992, Growth factors.
[6] N. Hooper,et al. Families of zinc metalloproteases , 1994, FEBS letters.
[7] A. Prat,et al. N-arginine dibasic convertase, a metalloendopeptidase as a prototype of a class of processing enzymes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[8] A. Prat,et al. N‐arginine dibasic convertase is a specific receptor for heparin‐binding EGF‐like growth factor that mediates cell migration , 2001, The EMBO journal.
[9] C. Boone,et al. Role of Yeast Insulin-Degrading Enzyme Homologs in Propheromone Processing and Bud Site Selection , 1995, Science.
[10] J. Dixon,et al. New vectors for high level expression of recombinant proteins in bacteria. , 1992, Analytical biochemistry.
[11] A. Simeone,et al. Human NRD convertase: a highly conserved metalloendopeptidase expressed at specific sites during development and in adult tissues. , 1998, Genomics.
[12] M. Klagsbrun,et al. Activation of HER4 by heparin‐binding EGF‐like growth factor stimulates chemotaxis but not proliferation , 1997, The EMBO journal.
[13] A. Serero,et al. Identification of eukaryotic peptide deformylases reveals universality of N‐terminal protein processing mechanisms , 2000, The EMBO journal.
[14] L. Hersh,et al. Expression of the acidic stretch of nardilysin as a functional binding domain. , 2001, Biochemistry.
[15] R. Karam,et al. CARDIAC HYPERTROPHY , 2004 .
[16] M. Kozak. An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. , 1987, Nucleic acids research.
[17] A. Ullrich,et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF , 1999, Nature.
[18] C. Créminon,et al. Isolation and characterization of a dibasic selective metalloendopeptidase from rat testes that cleaves at the amino terminus of arginine residues. , 1994, The Journal of biological chemistry.
[19] L. Hersh,et al. Purification and characterization of a secreted arginine-specific dibasic cleaving enzyme from EL-4 cells. , 1995, Biochemistry.
[20] A. Prat,et al. NRD convertase: a putative processing endoprotease associated with the axoneme and the manchette in late spermatids. , 1996, Journal of cell science.
[21] J. Abraham,et al. Characterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparin. , 1994, The Journal of biological chemistry.
[22] H. Braun,et al. Are the 'core' proteins of the mitochondrial bc1 complex evolutionary relics of a processing protease? , 1995, Trends in biochemical sciences.
[23] A. Morel,et al. Enzymes that process somatostatin precursors. A novel endoprotease that cleaves before the arginine-lysine doublet is involved in somatostatin-28 convertase activity of rat brain cortex. , 1987, The Journal of biological chemistry.
[24] S. Baksh,et al. Expression of calreticulin in Escherichia coli and identification of its Ca2+ binding domains. , 1991, The Journal of biological chemistry.
[25] L. Hersh,et al. Regulation of N-arginine dibasic convertase activity by amines: putative role of a novel acidic domain as an amine binding site. , 1998, Biochemistry.
[26] J. Xu,et al. An essential heparin-binding domain in the fibroblast growth factor receptor kinase. , 1993, Science.
[27] M. Klagsbrun,et al. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF , 1991, Science.
[28] D. Richter,et al. The rat insulin‐degrading enzyme , 1993, FEBS letters.
[29] L. Pannell,et al. Carboxypeptidase E Is a Regulated Secretory Pathway Sorting Receptor: Genetic Obliteration Leads to Endocrine Disorders in Cpefat Mice , 1997, Cell.
[30] M. Klagsbrun,et al. Heparin-binding EGF-like growth factor. , 1997, Biochimica et biophysica acta.
[31] M. Kozak. Initiation of translation in prokaryotes and eukaryotes. , 1999, Gene.
[32] V. Fried,et al. Human insulin-degrading enzyme shares structural and functional homologies with E. coli protease III. , 1988, Science.
[33] A. Prat,et al. N-arginine dibasic convertase (nardilysin) isoforms are soluble dibasic-specific metalloendopeptidases that localize in the cytoplasm and at the cell surface. , 2000, The Biochemical journal.
[34] Gene expression of the dibasic-pair cleaving enzyme NRD convertase (N-arginine dibasic convertase) is differentially regulated in the GH3 pituitary and Mat-Lu prostate cell lines. , 2000, The Biochemical journal.
[35] A. Prat,et al. Human and rat testis express two mRNA species encoding variants of NRD convertase, a metalloendopeptidase of the insulinase family. , 1997, The Biochemical journal.
[36] L. Hersh,et al. Studies on the Subsite Specificity of Rat Nardilysin (N-Arginine Dibasic Convertase)* , 2000, The Journal of Biological Chemistry.
[37] Hiroshi Asanuma,et al. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy , 2002, Nature Medicine.